Open AccessHemophagocytic Lymphohistiocytosis Secondary to Immune Checkpoint Inhibitor Therapy
Author(s) -
Pramuditha Rajapakse,
Haripriya Andanamala
Publication year - 2022
Publication title -
world journal of oncology
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1920-454X
pISSN - 1920-4531
DOI - 10.14740/wjon1464
Subject(s) - medicine , nivolumab , ipilimumab , pembrolizumab , immunotherapy , hemophagocytic lymphohistiocytosis , adverse effect , pediatrics , immunology , immune system , disease